Overview

HCV-796 and Midazolam Drug Interaction Study in Healthy Subjects

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
0
Participant gender:
All
Summary
To evaluate the potential PK interaction of multiple oral doses of HCV-796 and a single oral dose of midazolam when coadministered to healthy subjects.
Phase:
Phase 1
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Midazolam
Criteria
Inclusion Criteria:

- Healthy as determined by investigator on the basis of medical history, physical
examination, clinical laboratory test results, vital signs and 12-lead ECG.